FFCP PHASE1:Mm9::chr12:70639273..70639286,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=167|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:70639273..70639286,+|id=chr12:70639273..70639286,+|ontology_enrichment_celltype=CL:0000063!1.35e-10!66;CL:0000219!4.42e-10!54;CL:0000988!1.69e-09!32;CL:0002032!1.69e-09!32;CL:0000037!1.69e-09!32;CL:0000566!1.69e-09!32;CL:0000837!1.69e-09!32;CL:0002320!5.50e-09!46;CL:0000134!5.50e-09!46;CL:0000144!5.74e-09!121;CL:0000012!5.74e-09!121;CL:0000049!1.21e-08!19|ontology_enrichment_celltype_v019_2=CL:0000049,1.11e-14,19;CL:0000988,8.29e-09,32;CL:0002032,8.29e-09,32;CL:0000037,8.29e-09,32;CL:0000837,8.29e-09,32;CL:0000557,3.52e-07,7;CL:0000034,3.71e-07,97|ontology_enrichment_disease=|ontology_enrichment_disease_v019_2=|ontology_enrichment_uberon=UBERON:0002384!5.50e-09!46|ontology_enrichment_uberon_v019_2=|phase1_expression=0.160148847104794,0,0,0,0,0,0.233612640595526,0,0.563154888606667,0,0,0,0,0,0,0,0,0,0.137114433605739,0,0,0,0.261199789138935,0,0,0,0.430761996159075,0,0,0,0,0,0,0,0,0,0,0,0,0,0.588231488031014,0,0,0,0,0,0,0,0,0,0.139986421625363,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0.579728977403356,0,0.679971333707751,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0.144599356919912,0,0,0.220841518460394,0,0,0,0,0,3.83408398418945,5.99902730993408,3.68503658511888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.91549231119264,3.60287069960601,0.852490498186778,0.414251545071004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102904612379284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.73952545986482,5.59805809294632,3.17859939750175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:70639273..70639286,+}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=167 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:70639273..70639286,+ | |||
|description=CAGE_peak_at_chr12:70639273..70639286,+ | |||
|id=chr12:70639273..70639286,+ | |||
|ontology_enrichment_celltype=CL:0000063!1.35e-10!66;CL:0000219!4.42e-10!54;CL:0000988!1.69e-09!32;CL:0002032!1.69e-09!32;CL:0000037!1.69e-09!32;CL:0000566!1.69e-09!32;CL:0000837!1.69e-09!32;CL:0002320!5.50e-09!46;CL:0000134!5.50e-09!46;CL:0000144!5.74e-09!121;CL:0000012!5.74e-09!121;CL:0000049!1.21e-08!19 | |||
|ontology_enrichment_celltype_v019_2=CL:0000049,1.11e-14,19;CL:0000988,8.29e-09,32;CL:0002032,8.29e-09,32;CL:0000037,8.29e-09,32;CL:0000837,8.29e-09,32;CL:0000557,3.52e-07,7;CL:0000034,3.71e-07,97 | |||
|ontology_enrichment_disease= | |||
|ontology_enrichment_disease_v019_2= | |||
|ontology_enrichment_uberon=UBERON:0002384!5.50e-09!46 | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0.160148847104794,0,0,0,0,0,0.233612640595526,0,0.563154888606667,0,0,0,0,0,0,0,0,0,0.137114433605739,0,0,0,0.261199789138935,0,0,0,0.430761996159075,0,0,0,0,0,0,0,0,0,0,0,0,0,0.588231488031014,0,0,0,0,0,0,0,0,0,0.139986421625363,0,0.167782606057736,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0755715601067855,0.579728977403356,0,0.679971333707751,0,0,0,0,0,0,0,0,0,0,0,0,0,0.505524445014783,0,0,0,0,0,0,0,0,0,0,0.144599356919912,0,0,0.220841518460394,0,0,0,0,0,3.83408398418945,5.99902730993408,3.68503658511888,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,4.91549231119264,3.60287069960601,0.852490498186778,0.414251545071004,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.102904612379284,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.73952545986482,5.59805809294632,3.17859939750175,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:70639273..70639286,+ | |||
}} |
Latest revision as of 04:16, 5 August 2015
Short description: | p@chr12:70639273..70639286, + |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:70639273..70639286, + |
Coexpression cluster: | MCL_coexpression_mm9:167 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
common myeloid progenitor | 1.11e-14 | 19 |
hematopoietic cell | 8.29e-09 | 32 |
hematopoietic oligopotent progenitor cell | 8.29e-09 | 32 |
hematopoietic stem cell | 8.29e-09 | 32 |
hematopoietic multipotent progenitor cell | 8.29e-09 | 32 |
granulocyte monocyte progenitor cell | 3.52e-07 | 7 |
stem cell | 3.71e-07 | 97 |